About TransMedics
TransMedics is a company based in Andover (United States) founded in 1998.. TransMedics has raised $265.55 million across 16 funding rounds from investors including Canadian Imperial Bank of Commerce, United Therapeutics and Kleiner Perkins. The company has 728 employees as of December 31, 2024. TransMedics has completed 2 acquisitions, including Summit Aviation and TransMedics Aviation. TransMedics offers products and services including OCS Lung, OCS Heart, OCS Liver, and OCS DCD Heart. TransMedics operates in a competitive market with competitors including OrganOx, Paragonix Technologies, Bridge to Life, Vascular Perfusion and ADVITOS, among others.
- Headquarter Andover, United States
- Employees 728 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Transmedics Group, Inc.
-
Annual Revenue
$441.54 M82.74as on Dec 31, 2024
-
Net Profit
$35.46 M241.67as on Dec 31, 2024
-
EBITDA
$57.25 M553.44as on Dec 31, 2024
-
Total Equity Funding
$265.55 M (USD)
in 16 rounds
-
Latest Funding Round
$60 M (USD), Debt – Conventional
Sep 15, 2022
-
Investors
Canadian Imperial Bank of Commerce
& 15 more
-
Employee Count
728
as on Dec 31, 2024
-
Investments & Acquisitions
Summit Aviation
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of TransMedics
TransMedics is a publicly listed company on the NASDAQ with ticker symbol TMDX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of TransMedics
TransMedics offers a comprehensive portfolio of products and services, including OCS Lung, OCS Heart, OCS Liver, and OCS DCD Heart. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Technology for preserving lungs during transplantation procedures
Device for maintaining heart viability in transplants
System to preserve livers for successful transplantation
Approved technology for hearts from donation after circulatory death
Unlock access to complete
Unlock access to complete
Funding Insights of TransMedics
TransMedics has successfully raised a total of $265.55M across 16 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $60 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 16
- Last Round Debt – Conventional — $60.0M
-
First Round
First Round
(01 Sep 2000)
- Investors Count 16
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2022 | Amount | Debt – Conventional - TransMedics | Valuation |
investors |
|
| Jul, 2016 | Amount | Series F - TransMedics | Valuation | Pharmstandard International , BioStar Capital | |
| Sep, 2015 | Amount | Series F - TransMedics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in TransMedics
TransMedics has secured backing from 16 investors, including institutional and venture fund investors. Prominent investors backing the company include Canadian Imperial Bank of Commerce, United Therapeutics and Kleiner Perkins. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are managed by Abrams Capital across the United States.
|
Founded Year | Domain | Location | |
|
Life sciences-focused venture capital firm
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in early-stage tech startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by TransMedics
TransMedics has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Summit Aviation and TransMedics Aviation. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Aviation degrees and flight training services are provided.
|
2000 | ||||
|
Full service aviation centre offering aircraft maintenance, repair, modifications, flight school, private jet charter, and aircraft management solutions
|
1960 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - TransMedics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Transmedics Comparisons
Competitors of TransMedics
TransMedics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OrganOx, Paragonix Technologies, Bridge to Life, Vascular Perfusion and ADVITOS, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Warm storage and transport systems for harvested organs are provided.
|
|
| domain | founded_year | HQ Location |
Organ preservation and transport systems are developed for transplants.
|
|
| domain | founded_year | HQ Location |
Cold storage solutions for organ transplant preservation are provided.
|
|
| domain | founded_year | HQ Location |
Developer of a device for organ preservation
|
|
| domain | founded_year | HQ Location |
Multi-organ support systems for liver, lung, and kidney are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Transmedics
Frequently Asked Questions about TransMedics
When was TransMedics founded?
TransMedics was founded in 1998 and raised its 1st funding round 2 years after it was founded.
Where is TransMedics located?
TransMedics is headquartered in Andover, United States. It is registered at Andover, Massachusetts, United States.
Is TransMedics a funded company?
TransMedics is a funded company, having raised a total of $265.55M across 16 funding rounds to date. The company's 1st funding round was a Series F of $500K, raised on Sep 01, 2000.
How many employees does TransMedics have?
As of Dec 31, 2024, the latest employee count at TransMedics is 728.
What is the annual revenue of TransMedics?
Annual revenue of TransMedics is $441.54M as on Dec 31, 2024.
What does TransMedics do?
TransMedics was founded in 1998 in Andover, United States, within the medical device sector focused on organ transplantation. The Organ Care System (OCS) has been created as a portable technology that keeps organs functioning outside the body, featuring a wireless monitor, organ-specific perfusion module, and solution set. Versions for heart, lungs, and liver are available, with commercial distribution occurring in Europe and Australia.
Who are the top competitors of TransMedics?
TransMedics's top competitors include OrganOx, ADVITOS and Paragonix Technologies.
What products or services does TransMedics offer?
TransMedics offers OCS Lung, OCS Heart, OCS Liver, and OCS DCD Heart.
Is TransMedics publicly traded?
Yes, TransMedics is publicly traded on NASDAQ under the ticker symbol TMDX.
How many acquisitions has TransMedics made?
TransMedics has made 2 acquisitions, including Summit Aviation, and TransMedics Aviation.
Who are TransMedics's investors?
TransMedics has 16 investors. Key investors include Canadian Imperial Bank of Commerce, United Therapeutics, Kleiner Perkins, Hercules Capital, and Flagship Pioneering.
What is TransMedics's ticker symbol?
The ticker symbol of TransMedics is TMDX on NASDAQ.